News

Novavax (NVAX) Is Up After FDA Approves Updated Nuvaxovid for Key High-Risk Groups—What's Changed

On August 27, 2025, Novavax announced that the U.S. FDA approved the Nuvaxovid 2025-2026 COVID-19 vaccine formula for adults 65 and older, as well as individuals ages 12-64 with underlying conditions ...

FDA approves updated Covid-19 vaccines for limited groups as US cases continue to rise

The U.S. Food and Drug Administration approved updated COVID-19 vaccines but for a more limited group: adults age 65 and ...

FDA approves updated Pfizer COVID shots but limits access for some kids and adults

The Food and Drug Administration has approved updated COVID-19 vaccines for the upcoming fall and winter season ...

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA

We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Novavax, Inc. is one of them. Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company specializing in ...

Novavax shares plummet 12% after debt refinancing plan and Bank of America downgrade

Shares in Gaithersburg biotech Novavax slid more than 12% in Thursday trading after announcing plans to refinance $225 ...

FDA authorizes updated COVID vaccines with restrictions on who can get them

The Food and Drug Administration rescinded the emergency use authorization that made COVID-19 shots available for healthy ...
New York Magazine on MSN4d

What to Know About the FDA’s New COVID Vaccine Restrictions

The Moderna and Pfizer vaccines have both been updated to target the newer LP.8.1 variant, which is the strain that now ...

RFK Jr. Reacts to New COVID Vaccine Plan Approved by FDA

The FDA's decision breaks sharply from previous policy, which recommended annual COVID-19 shots for nearly everyone 6 months ...